Literature DB >> 31564280

Adult Necrotising Enterocolitis in a Breast Cancer Patient after First Cycle of Adjuvant Chemotherapy.

Fatima Tuz Zahra Shakir1, Rizwan Sultan1, Riaz Siddiqui1, M Zubair Shah1, Ayesha Javed1.   

Abstract

Chemotherapy-induced diarrhea has become a worrisome problem for the patients as well as the treating surgeons and oncologists because patient outcome is significantly affected. Necrotising enterocolitis is a rare disease in adults. It is now termed as neutropenic enterocolitis in adults, because it is seen more often as a complication of aggressive systemic chemotherapy. It is believed to be associated with chemotherapy-induced intestinal mucosal injury followed by a super infection, which leads to bacteremia, and majority of these patient develop neutropenia. They often have vague and nonspecific presentation which gets overshadowed by the symptoms of primary malignant disease and expected toxic side effects of chemotherapy. In this case report, we discuss the case of a middle-aged female with infiltrating ductal carcinoma of breast, who on adjuvant chemotherapy, developed necrotising enterocolitis requiring emergency exploratory laparotomy. The objective of this study is to increase awareness regarding this fatal complication of chemotherapy because very little research has been done so far. We also review literature to find out the cause of necrotising enterocolitis in reported cases. It is recommended to treat diarrhea, caused by chemotherapy, with antibiotics instead of just loperamide because of decreased immunity of the patient, which could lead to fatal complications.

Entities:  

Mesh:

Year:  2019        PMID: 31564280     DOI: 10.29271/jcpsp.2019.10.1006

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  1 in total

1.  Neutropenic Enterocolitis in the Treatment of Solid Tumors: A Case Report and Review of the Literature.

Authors:  Sara Cherri; Tiziana Prochilo; Luigina Rota; Stefano Mutti; Marco Garatti; Barbara Liserre; Alberto Zaniboni
Journal:  Case Rep Oncol       Date:  2020-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.